Key Benefits of Dexamethasone and Antibody Treatment in COVID-19 Hamster Models Revealed by Single Cell Transcriptomics

Pulmonary viral burden was reduced by anti-SARS-CoV-2 antibody treatment, and similar or increased by dexamethasone alone. Dexamethasone exhibited strong anti-inflammatory effects and prevented fulminant disease in a severe disease model.